Literature DB >> 8403584

Detection and identification of antinuclear autoantibodies in the serum of normal blood donors.

K de Vlam1, F De Keyser, G Verbruggen, M Vandenbossche, B Vanneuville, D D'Haese, E M Veys.   

Abstract

The occurrence of antinuclear antibodies (ANA) in the serum of 485 healthy volunteer blood donors was assessed. Sixty two sera displayed nuclear immunofluorescence staining on Hep-2 cells using a polyvalent anti-Ig conjugate. In general, the titer of these antibodies was low (42/62 sera displaying a titer lower than or equal to 1:80). In only 23 sera were the ANA of the IgG isotype, which is the more disease-related immunoglobulin class of autoantibodies. In order to define the frequency of antibodies to extractable nuclear antigens and dsDNA within this population, sera were further analyzed by counterimmunoelectrophoresis. Western blot and the Crithidia luciliae assay. One serum displayed weak antids DNA reactivity; another serum had anti-SSA/Ro activity. On Western blot several patterns were found. They could not be identified with any of the available reference antisera.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8403584

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  20 in total

1.  Antibodies to extractable nuclear antigens. Has technological drift affected clinical interpretation?

Authors:  R J Lock; D J Unsworth
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

Review 2.  The use of laboratory tests in the diagnosis of SLE.

Authors:  W Egner
Journal:  J Clin Pathol       Date:  2000-06       Impact factor: 3.411

3.  Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.

Authors:  Insoo Kang; Robyn Siperstein; Tim Quan; Mary Lou Breitenstein
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

4.  Frequency and specificity of antibodies against nuclear and cytoplasmic antigens in healthy individuals by classic and new methods.

Authors:  E Giannouli; D Chatzidimitriou; S Gerou; E Gavriilaki; L Settas; E Diza
Journal:  Clin Rheumatol       Date:  2013-05-11       Impact factor: 2.980

5.  Determination of anti-nuclear antibody seroprevalence in adult age groups in trabzon province.

Authors:  Neşe Kaklıkkaya; Altan Akıneden; Murat Topbaş; Faruk Aydın
Journal:  Balkan Med J       Date:  2013-09       Impact factor: 2.021

6.  Occurence of autoantibodies in healthy Omani individuals.

Authors:  Ali A Al-Jabri; Elizabeth R Richens
Journal:  J Sci Res Med Sci       Date:  2001-04

Review 7.  Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance.

Authors:  Alla Ishchenko; Rik J Lories
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

8.  Comparison and variation of different methodologies for the detection of autoantibodies to nuclear antigens (ANA).

Authors:  C González; T Martin; T Arroyo; M García-Isidoro; J A Navajo; J M González-Buitrago
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

9.  Prevalence and sociodemographic correlates of antinuclear antibodies in the United States.

Authors:  Minoru Satoh; Edward K L Chan; Lindsey A Ho; Kathryn M Rose; Christine G Parks; Richard D Cohn; Todd A Jusko; Nigel J Walker; Dori R Germolec; Irene Z Whitt; Patrick W Crockett; Brad A Pauley; Jason Y F Chan; Steven J Ross; Linda S Birnbaum; Darryl C Zeldin; Frederick W Miller
Journal:  Arthritis Rheum       Date:  2012-07

Review 10.  The influence of ageing on the development and management of rheumatoid arthritis.

Authors:  Annemieke M H Boots; Andrea B Maier; Piet Stinissen; Pierre Masson; Rik J Lories; Filip De Keyser
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.